What is so-called 'Ozempic face' and how does it develop?
Rapid fat loss caused by semaglutide and related drugs can visibly hollow out the face, and the effect appears greater than weight loss alone explains. Whether and how best to correct this remains poorly studied.
On average, the mid-face loses about 9% of its volume in people who use semaglutide. That sounds modest, but in the face it is visible: the cheeks become hollow, wrinkles deepen and the skin hangs more loosely. Roughly 7% of facial volume disappears for every 10 kilograms a person loses, and it is primarily the superficial fat layers beneath the skin that are drawn upon first.
Notably, the facial volume loss appears greater than you would expect based purely on the total amount of weight lost. Review articles suggest that GLP-1 receptor agonists (the class of drugs to which semaglutide and tirzepatide belong) may act locally on facial fat, adipose-tissue stem cells and the hormone-like substances that fat tissue releases. This could also affect skin structure and muscle mass in the face. These are theoretical explanations for now, not confirmed in controlled studies.
A small study of 18 users and 18 non-users found, unexpectedly, that the area around the mouth was slightly larger in users than in the control group. This is an unexpected finding whose significance is unclear; the study is too small to draw firm conclusions from.
Beyond the face, these drugs regularly cause gastrointestinal complaints such as nausea, vomiting and diarrhoea. They also slow gastric emptying, which is relevant for people undergoing surgery: doctors advise stopping them in good time before anaesthesia. A possible link with thyroid tumours is mentioned in the literature but has not yet been clarified.
'Ozempic face' has by now led to increased demand for fillers, biostimulating injections, skin-tightening treatments and even surgery. Review authors agree that solid research into the effectiveness and safety of all those corrective treatments in this patient group is largely absent.
The evidence rests on a small imaging study of 20 patients, multiple review articles and a small comparative study with 18 participants per group. The imaging study provides the only concrete measurement (9% volume loss) but has a small sample size. The mechanistic explanations come largely from reviews and have not yet been tested in controlled studies in humans. Systematic research on the corrective treatments is almost entirely lacking.
How do you safely taper off Ozempic?
Whether gradual tapering is better than stopping abruptly is not yet known, but stopping abruptly leads to weight regain and worsening of blood pressure and other values in most people. Always discuss a stopping plan with your doctor, especially if you are also using the medication for your heart or for diabetes.
How does nutrition strengthen your immune system?
Nutrition has a clear influence on the immune system: deficiencies weaken your defences, and correcting a demonstrable deficiency (especially of vitamin D, C and zinc) helps. In people without a deficiency, the case for extra supplementation is less convincingly proven.
Does poor sleep increase my risk of cancer?
Poor sleep, and sleep apnea and night-shift work in particular, is associated with an increased cancer risk. Whether you personally face a higher risk depends on which sleep problems you have; at the very least, have any apnea symptoms evaluated.